Target-focused pharmacophore modeling

webinar

Tue, 24 Apr 2018, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Charité

Target-focused pharmacophore modeling

Various computational tools and molecular modeling platforms are known to support medicinal chemists in understanding bioactivities, predicting binding events and rationally designing drug molecules. Among them, the pharmacophore approach is an accurate and minimal 3D-abstraction of chemical structures and intermolecular interactions.

Pharmacophore models are usually derived from a group of molecules in absence of structural information on their biological targets (ligand-based approach) or from a ligand-target complex (structure-based approach). However, only a limited amount of solutions exists to model comprehensive pharmacophores using the information of a particular target structure without knowledge of any binding ligand. In the presented work, T2F-Pharm, a fully automated tool for Truly Target-Focused Pharmacophore modeling will be introduced. Using a grid-based approach, this method samples the protein cavity, filters the grid points by energy level and clusters them into low energy hot spots. Subsequently, key features in the pocket required for optimal interaction in a 3D-pharmacophore model are derived.

T2F-Pharm represents a valuable instrument for drug discovery to investigate protein surfaces in absence of known binding partners, e.g. in cases of rather unexplored binding sites including allosteric pockets.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on